PD1-IL2

N/A

Report date: 2025/01/26 19:28:54

Base Information

Drug NamePD1-IL2
Drug Alias Namedual PD-L1 checkpoint inhibitor/IL-2 (Good Therapeutics)PD1-IL2
ClassificationBiologics
Mechanisms of ActionInterleukin-2 receptor agonistsProgrammed cell death protein 1 blockers
TargetsInterleukin-2 receptorProgrammed cell death protein 1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesGood Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesGood Therapeutics
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A